Article Details

Analysts Set Summit Therapeutics (SMMT) Price Target at $26.83

Retrieved on: 2018-05-16 07:47:29

Tags for this article:

Click the tags to see associated articles and topics

Analysts Set Summit Therapeutics (SMMT) Price Target at $26.83. View article details on hiswai:

Excerpt

<div>Finally, <b>Acadian Asset Management</b> LLC lifted its holdings in shares of Summit Therapeutics by 192.8% during the fourth quarter. <b>Acadian Asset</b> ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up